A Two-Part, Phase 1, Single and Multiple Ascending Dose Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of CAT-2003 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 02 May 2014
At a glance
- Drugs CAT 2003 (Primary)
- Indications Hypertriglyceridaemia
- Focus Adverse reactions
- Sponsors Catabasis Pharmaceuticals
- 02 May 2014 Results presented at the National Lipid Association (NLA) Scientific Sessions 2014, according to to a Catabasis media release.
- 31 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.
- 31 Mar 2014 Results will be presented at the American College of Cardiology's 63rd Annual Scientific Session (ACC.14) according to a Catabasis media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History